Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
Nat Commun. 2024 Jan 2;15(1):89. doi: 10.1038/s41467-023-44310-y.
Nat Commun. 2024.
PMID: 38167707
Free PMC article.
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer.
Beckabir W, Wobker SE, Damrauer JS, Midkiff B, De la Cruz G, Makarov V, Flick L, Woodcock MG, Grivas P, Bjurlin MA, Harrison MR, Vincent BG, Rose TL, Gupta S, Kim WY, Milowsky MI.
Beckabir W, et al. Among authors: woodcock mg.
Eur Urol. 2024 Mar;85(3):242-253. doi: 10.1016/j.eururo.2023.11.008. Epub 2023 Dec 12.
Eur Urol. 2024.
PMID: 38092611
Free PMC article.
Item in Clipboard
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.
Routh ED, Woodcock MG, Beckabir W, Vensko SP, Serody JS, Vincent BG.
Routh ED, et al. Among authors: woodcock mg.
J Immunother Cancer. 2023 Mar;11(3):e005848. doi: 10.1136/jitc-2022-005848.
J Immunother Cancer. 2023.
PMID: 36882226
Free PMC article.
Item in Clipboard
Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition.
Tsai YS, Woodcock MG, Azam SH, Thorne LB, Kanchi KL, Parker JS, Vincent BG, Pecot CV.
Tsai YS, et al. Among authors: woodcock mg.
J Clin Invest. 2022 Feb 15;132(4):e155523. doi: 10.1172/JCI155523.
J Clin Invest. 2022.
PMID: 34990404
Free PMC article.
Item in Clipboard
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Routh ED, Van Swearingen AED, Sambade MJ, Vensko S, McClure MB, Woodcock MG, Chai S, Cuaboy LA, Wheless A, Garrett A, Carey LA, Hoyle AP, Parker JS, Vincent BG, Anders CK.
Routh ED, et al. Among authors: woodcock mg.
Front Oncol. 2022 Jul 27;12:818693. doi: 10.3389/fonc.2022.818693. eCollection 2022.
Front Oncol. 2022.
PMID: 35992833
Free PMC article.
Item in Clipboard
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.
Bortone DS, Woodcock MG, Parker JS, Vincent BG.
Bortone DS, et al. Among authors: woodcock mg.
Cancer Immunol Res. 2021 Jan;9(1):103-112. doi: 10.1158/2326-6066.CIR-20-0398. Epub 2020 Nov 11.
Cancer Immunol Res. 2021.
PMID: 33177107
Item in Clipboard
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
Anders CK, Woodcock MG, Van Swearingen AED, Moore DT, Sambade MJ, Laurie S, Robeson A, Kolupaev O, Cuaboy LA, Garrett AL, McKinnon K, Cowens K, Bortone D, Calhoun BC, Wilkinson AD, Carey L, Jolly T, Muss H, Reeder-Hayes K, Kaltman R, Jankowitz R, Gudena V, Olajide O, Perou C, Dees EC, Vincent BG, Serody JS.
Anders CK, et al. Among authors: woodcock mg.
J Immunother Cancer. 2022 Feb;10(2):e003427. doi: 10.1136/jitc-2021-003427.
J Immunother Cancer. 2022.
PMID: 35121644
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite